Extract from the Register of European Patents

EP About this file: EP2283817

EP2283817 - Method of making particles for use in a pharmaceutical composition [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  30.11.2022
Database last updated on 11.04.2026
FormerThe patent has been granted
Status updated on  25.03.2020
Most recent event   Tooltip02.12.2022Revocation of patentpublished on 04.01.2023  [2023/01]
Applicant(s)For all designated states
Vectura Limited
1 Prospect West
Chippenham, Wiltshire SN14 6FH / GB
[2011/07]
Inventor(s)01 / Staniforth, John
The Byre
Claverton
Bath, BA2 7BG / GB
02 / Green, Matthew, Michael, James
Vectural Limited
5 St Lawrence way
Caterham, Surrey, Surrey CR3 5FD / GB
03 / Morton, David, Alexander, Vodden
Vectura Limited
2nd Floor Flat
Linsley House
Beechen Cliff House
Bath, Bath and North East Somerset BA2 4QR / GB
 [2016/20]
Former [2011/11]01 / Staniforth, John
The Byre Claverton
Bath, BA2 7BG / GB
02 / Green, Matthew, Michael, James
Vectural Limited 5 St Lawrence way
Caterham, Surrey, Surrey CR3 5FD / GB
03 / Morton, David, Alexander, Vodden
Vectura Limited 2nd Floor Flat Linsley House Beechen Cliff House
Bath, Bath and North East Somerset BA2 4QR / GB
Former [2011/07]01 / Staniforth, John
Vectura Limited High Trees 170 Bloomfield Road
Bath, Bath and North East Somerset BA2 2ST / GB
02 / Green, Matthew, Michael, James
Vectural Limited 5 St Lawrence way
Caterham, Surrey, Surrey CR3 5FD / GB
03 / Morton, David, Alexander, Vodden
Vectura Limited 2nd Floor Flat Linsley House Beechen Cliff House
Bath, Bath and North East Somerset BA2 4QR / GB
Representative(s)CMS Cameron McKenna Nabarro Olswang LLP
Cannon Place
78 Cannon Street
London EC4N 6AF / GB
[N/P]
Former [2012/34]Stephen, Robert John
Olswang LLP 90 High Holborn
London WC1V 6XX / GB
Former [2011/07]McNamara, Kathryn, et al
Venner Shipley LLP Byron House Cambridge Business Park Cowley Road
Cambridge CB4 0WZ / GB
Application number, filing date10181899.530.11.2001
[2011/07]
Priority number, dateGB2000002926130.11.2000         Original published format: GB 0029261
GB2000003094619.12.2000         Original published format: GB 0030946
WO2001GB0160609.04.2001         Original published format: PCT/GB01/01606
GB2001002401005.10.2001         Original published format: GB 0124010
[2011/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2283817
Date:16.02.2011
Language:EN
[2011/07]
Type: B1 Patent specification 
No.:EP2283817
Date:18.05.2016
Language:EN
[2016/20]
Search report(s)(Supplementary) European search report - dispatched on:EP21.12.2010
ClassificationIPC:A61K9/14, A61K9/72, A61K9/00
[2011/07]
CPC:
A61K9/0075 (EP,US); A61K9/5115 (US); A61K31/137 (EP,US);
A61K47/06 (US); A61K47/10 (US); A61K47/12 (US);
A61K47/32 (US); A61K47/44 (EP); A61K9/008 (EP,US);
A61K9/145 (EP,US); A61K9/1617 (EP,US); A61K9/167 (US);
A61K9/50 (US); A61K9/501 (US); A61K9/5015 (US);
A61K9/5089 (US); A61P11/06 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE,   TR [2016/20]
Former [2011/07]AT,  BE,  CH,  CY,  DE,  DK,  ES,  FI,  FR,  GB,  GR,  IE,  IT,  LI,  LU,  MC,  NL,  PT,  SE,  TR 
TitleGerman:Herstellungsverfahren für Partikel zur Verwendung in einer Arrzneizusammensetzung[2011/07]
English:Method of making particles for use in a pharmaceutical composition[2011/07]
French:Procédé de préparation de particules destinées à être utilisées dans une composition pharmaceutique[2011/07]
Examination procedure16.08.2011Amendment by applicant (claims and/or description)
16.08.2011Examination requested  [2011/38]
05.12.2011Despatch of a communication from the examining division (Time limit: M06)
20.07.2012Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
21.09.2012Reply to a communication from the examining division
19.09.2014Despatch of a communication from the examining division (Time limit: M04)
29.01.2015Reply to a communication from the examining division
02.06.2015Despatch of a communication from the examining division (Time limit: M04)
20.08.2015Reply to a communication from the examining division
04.01.2016Communication of intention to grant the patent
05.04.2016Fee for grant paid
05.04.2016Fee for publishing/printing paid
05.04.2016Receipt of the translation of the claim(s)
30.07.2020Observations by third parties
Parent application(s)   TooltipEP01998328.7  / EP1337240
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010998328) is  02.09.2005
Opposition(s)Opponent(s)01  16.02.2017  21.02.2017  ADMISSIBLE
Glaxo Group Limited
980 Great West Road
Brentford Middlesex TW8 9GS / GB
Opponent's representative
J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
 [N/P]
Former [2020/35]
Opponent(s)01  16.02.2017  21.02.2017  ADMISSIBLE
Glaxo Group Limited
980 Great West Road
Brentford Middlesex TW8 9GS / GB
Opponent's representative
J A Kemp LLP
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Former [2017/12]
Opponent(s)01  16.02.2017   
Glaxo Group Limited
980 Great West Road
Brentford Middlesex TW8 9GS / GB
Opponent's representative
Gladwin, Amanda Rachel
GlaxoSmithKline
Global Patents (CN925.1)
980 Great West Road
Brentford, Middlesex TW8 9GS / GB
deletedDeletion: Legal effect of rejection of opposition [ N /P ]
31.03.2017Invitation to proprietor to file observations on the notice of opposition
10.08.2017Reply of patent proprietor to notice(s) of opposition
04.06.2019Date of oral proceedings
26.03.2020Despatch of minutes of oral proceedings
26.03.2020Date of despatch of rejection of opposition
07.11.2022Despatch of communication that the patent will be revoked
17.11.2022Legal effect of revocation of patent [2023/01]
Appeal following opposition02.04.2020Appeal received No.  T0951/20
30.07.2020Statement of grounds filed
02.11.2022Result of appeal procedure: revocation of the patent
07.11.2022Despatch of the decision of the Board of Appeal
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
21.09.2012Request for further processing filed
21.09.2012Full payment received (date of receipt of payment)
Request granted
16.11.2012Decision despatched
Fees paidRenewal fee
24.01.2011Renewal fee patent year 03
24.01.2011Renewal fee patent year 04
24.01.2011Renewal fee patent year 05
24.01.2011Renewal fee patent year 06
24.01.2011Renewal fee patent year 07
24.01.2011Renewal fee patent year 08
24.01.2011Renewal fee patent year 09
28.03.2011Renewal fee patent year 10
29.11.2011Renewal fee patent year 11
29.11.2012Renewal fee patent year 12
27.11.2013Renewal fee patent year 13
26.11.2014Renewal fee patent year 14
30.11.2015Renewal fee patent year 15
Penalty fee
Additional fee for renewal fee
30.11.201010   M06   Fee paid on   28.03.2011
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipGB19.12.2019
IE30.11.2021
ES01.12.2021
PT10.12.2021
[2022/23]
Former [2022/11]GB19.12.2019
IE30.11.2021
PT10.12.2021
Former [2022/07]GB19.12.2019
IE30.11.2021
Former [2020/37]GB19.12.2019
Documents cited:Search[X] WO0027363  (NANOSYSTEMS et al.)
 [X] US5506203  (BAECKSTROEM KJELL G E et al.)
 [XD] WO9703649  (CO ORDINATED DRUG DEV LTD et al.)
 [X] WO9938493  (RTP PHARMA INC et al.)
 [X] US5663198  (REUL BERNHARD et al.)
 [X] WO9619199  (ASTRA AB et al.)
ExaminationWO0033811
   PEART J ET AL: "MULTICOMPONENT PARTICLE INTERACTIONS IN DRY POWDER AEROSOLS", PHARMACEUTICAL RESEARCH, SPRINGER NEW YORK LLC, US, vol. 14, no. 11-S, 1 January 1997 (1997-01-01), pages S142/S143, XP001030455, ISSN: 0724-8741
by applicantWO9703649
otherGB0029261
 GB0030946
 GB0101606
 GB0124010
 WO0176575
OppositionWO0027363
 WO0053158
 WO0053157
 US5145684
 WO9703649
 WO9938493
 WO0243700
 GB0124009
 WO0176575
 GB1381872
 GB0029261
 GB0030946
 GB0101606
 GB0124010
   PEART, JOANNE ET AL.: "Multicomponent particle interactions in dry powder aerosols", PHARMACEUTICAL RESEARCH, vol. 14, 1997, pages S142 - S143, XP001030455
   KAWASHIMA, YOSHIAKI ET AL.: "Design of inhalation dry powder of pranlukast hydrate to improve dispersibility by the surface modification with light anhydrous silicic acid (AEROSIL 200)", INTERNATIONAL JOURNAL OF PHARMACEUTICS, vol. 173, 1998, pages 243 - 251, XP055190780

DOI:   http://dx.doi.org/10.1016/S0378-5173(98)00243-9
   KOISHI, MASUMI ET AL.: "Preparation and surface properties of encapsulated powder pharmaceuticals", APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, vol. 10, 1984, pages 259 - 262, XP035178042

DOI:   http://dx.doi.org/10.1007/BF02783759
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.